Archive for the ‘Neurology / Neuroscience’ Category

Alzheimer’s Curbed By Promising New Drug

Sunday, August 3rd, 2008

A new drug that has completed phase 2 trials in the UK and Singapore is being hailed as a major breakthrough in the treatment of Alzheimer's, as it appeared to slow the progress of the disease by as much as 81 per cent over a year, compared to placebo. Methylthioninium ...

Stem Cell Therapeutics Corp. To Present Published Data At The IXth World Conference On Clinical Pharmacology & Therapeutics

Sunday, August 3rd, 2008

Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) announced that Dr. Allen Davidoff, VP Product Development, will be presenting data from the Phase I open labeled, uncontrolled pharmacokinetic study of a single intra-muscular (IM) hCG dose in healthy male volunteers at the IXth World Conference on Clinical Pharmacology and Therapeutics ...

Alzheimer’s Society Comment On Research Into Statins And Dementia

Sunday, August 3rd, 2008

Statins are increasingly hitting the headlines as a potential cure for dementia. The jury is still out on how effective they are, but this study adds to growing evidence that they may have some benefits. All drugs have some side-effects so it is important to seek professional advice about medication. ...

Minimizing Neurological Damage From Infant At-Birth Trauma With Moderate Whole-Body Cooling - Children’s Hospital Boston

Sunday, August 3rd, 2008

Cincinnati Sub-Zero (CSZ) Medical, a division of CSZ Products, Inc. and the leader in the design and development of advanced patient temperature management solutions, today announced its inclusion in the implementation of a neonatal therapeutic hypothermia protocol by Children's Hospital Boston. The hospital was the first to offer the treatment ...

Experts At Anavex Offer A Primer On Promising ‘Oxidative Stress’ Theory

Sunday, August 3rd, 2008

As trials on anti-amyloid vaccines continue to fail in the search for a viable Alzheimer's drug, a new approach - oxidative stress - is starting to emerge as a contender. Anavex Life Sciences (AVXL.OB) is leading this promising avenue of research. It has developed an ...

Disrupted Communication Networks In Brain Lead To Autism’s Social Struggles

Sunday, August 3rd, 2008

Picking up on innuendo and social cues is a central component of engaging in conversation, but people with autism often struggle to determine another person's intentions in a social interaction. New research from Carnegie Mellon University sheds light on the neural mechanisms that are responsible for such social difficulties in ...

Discovery Of Mechanism For Postpartum Depression In Mice May Lead To Better Treatments

Friday, August 1st, 2008

Researchers have pinpointed a mechanism in the brains of mice that could explain why some human mothers become depressed following childbirth. The discovery could lead to improved treatment for postpartum depression. Supported in part by the National Institute of Mental Health, of the National Institutes of Health, the study used ...

GE Healthcare Named “Pioneer In Technology” By International Brain Mapping & Intraoperative Surgical Planning Society

Friday, August 1st, 2008

The International Brain Mapping and Intraoperative Surgical Planning Society (IBMISPS) has recognized GE Healthcare with the Society's "Pioneer in Technology" award, rewarding GE's leading role in the development and commercialization of image-guided technologies in healthcare. The IBMISPS Pioneer Award is presented to companies and individuals who lead the fight for ...

Minimizing Traumatic Response To Bad Memories

Friday, August 1st, 2008

UC Irvine researchers have identified the brain mechanism that switches off traumatic feelings associated with bad memories, a finding that could lead to the development of drugs to treat panic disorders.Scientists from UCI and the University of Muenster in Germany found that a small brain protein called neuropeptide S is ...

UCB Receives Not-Approvable Letter From FDA For Lacosamide For Diabetic Neuropathic Pain

Friday, August 1st, 2008

UCB announced that it received a not-approvable letter from the U.S. Food and Drug Administration (FDA) for lacosamide for the treatment of diabetic neuropathic pain in adults. The company will seek clarification from the FDA of its position and of the additional information required to obtain final marketing ...

Memory Replay During Sleep Linked To Age - Or Is It?

Friday, August 1st, 2008

US scientists studying sleep processes in rats found that aging tended to impair the brain's ability to "replay" memories during sleep, a consolidation process that is important for converting recent memories into long term ones. However, impaired memory replay was not found in all the older rats tested in ...

The ‘Replay’ Of Memories During Sleep Impaired By Aging

Thursday, July 31st, 2008

Aging impairs the consolidation of memories during sleep, a process important in converting new memories into long-term ones, according to new animal research in the July 30 issue of The Journal of Neuroscience. The findings shed light on normal memory mechanisms and how they are disrupted by aging.During sleep, the ...

Infant Deaths Increasing Due To Preterm Birth

Thursday, July 31st, 2008

Babies born too soon and too small accounted for a growing proportion of infant deaths, according to new statistics released from the National Center for Health Statistics, (NCHS).Babies who died of preterm-related causes accounted for 36.5 percent of infant deaths in 2007, up from 34.6 percent in 2000, according to ...

Alzheimer’s Curbed By Promising New Drug

Wednesday, July 30th, 2008

A new drug that has completed phase 2 trials in the UK and Singapore is being hailed as a major breakthrough in the treatment of Alzheimer's, as it appeared to slow the progress of the disease by as much as 81 per cent over a year, compared to placebo. Methylthioninium ...

New Minimally Invasive Surgical Procedure Restores Quality Of Life In Patients With Potentially Debilitating Spinal Condition

Wednesday, July 30th, 2008

Early clinical results from the US and Argentina reveal that a new minimally invasive procedure successfully eliminates pain and disability caused by lumbar spinal stenosis (LSS), a condition that, in severe form, can cripple sufferers. Announced at the Society of NeuroInterventional Surgery (SNIS) Annual Meeting in Lake Tahoe, Calif., these ...